0001905495-25-000004.txt : 20251106 0001905495-25-000004.hdr.sgml : 20251106 20251106155347 ACCESSION NUMBER: 0001905495-25-000004 CONFORMED SUBMISSION TYPE: C/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20251106 DATE AS OF CHANGE: 20251106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CancerVAX, Inc. CENTRAL INDEX KEY: 0001905495 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 862876870 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: C/A SEC ACT: 1933 Act SEC FILE NUMBER: 020-35964 FILM NUMBER: 251457967 BUSINESS ADDRESS: STREET 1: 351 PASEO NUEVO, FLOOR 2 CITY: SANTA BARBARA STATE: CA ZIP: 93101 BUSINESS PHONE: (804) 356-1810 MAIL ADDRESS: STREET 1: 351 PASEO NUEVO, FLOOR 2 CITY: SANTA BARBARA STATE: CA ZIP: 93101 C/A 1 primary_doc.xml C/A 0001905495 XXXXXXXX 020-35964 LIVE false false false true Offering end date is being extended to January 12, 2026. CancerVAX, Inc. Corporation NV 03-23-2021 351 PASEO NUEVO, FLOOR 2 SANTA BARBARA CA 93101 www.cancervax.com N StartEngine Primary, LLC 0001725012 008-70060 7 - 13 percent One percent (1%) of securities of the total amount of investments raised in the offering, along the same terms as investors. Common Stock 4761 2.10000 N/A 9998.10 Y Other At issuer's discretion, with priority given to StartEngine Owners 1234999.50 01-12-2026 6.00 294703.00 204105.00 183505.00 138209.00 0.00 0.00 3421147.00 1684944.00 0.00 0.00 0.00 0.00 4245038.00 3418574.00 0.00 0.00 -7.36 -13.98 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY CancerVAX, Inc. Byron Horton Elton President, CEO, and Principal Accounting Officer Byron Horton Elton President, CEO, and Principal Accounting Officer 11-06-2025 Carla Miller Controller and Director 11-06-2025